Nepal Gives Approval For CoronaVac, COVID-19 Vaccine Produced By China's Sinovac, For Use In Nepal

Nepal Gives Approval For CoronaVac, COVID-19 Vaccine Produced By China's Sinovac, For Use In Nepal

June 4, 2021, 7:49 p.m.

The Department of Drug Administration (DDA) granted the approval for the use of CoronaVac, a Chinese COVID-19 vaccine, manufactured by Sinovac life sciences company limited, in Nepal.

The DDA has already given permission for the use of Sinopharm COVID-19 vaccine (commonly understood as Vero Cell in Nepal), another Chinese COVID-19 vaccine, produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).

China has provided 1.8 million doses of Sinopharm COVID-19 vaccine as grant assistance to Nepal.

World Health Organisation (WHO) has listed both the COVID-19 vaccines for emergency use, giving the green light for these vaccines to be rolled out globally.

More on National

The Latest

Latest Magazine

VOL. 14, No. 19, June 18, 2021 (Asadh 4, 2078) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14, No. 18, June 04, 2021 (Jestha 21, 2078) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14, No. 17, May 09, 2021 (Baisakh 26, 2078) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75

VOL. 14 No. 16, April 16, 2021 (Baisakh 03, 2078) Publisher: Keshab Prasad Poudel Online Register Number: DOI 584/074-75